Immuno-Modulatory activity of Mukta Bhasma (Calx of Cultured Pearls)
DOI:
https://doi.org/10.47552/ijam.v16i2.5389Keywords:
Immuno-modulatory activity, Mukta Bhasma, Rasayana, NBT assay & Phagocytosis, Candidacidal assay, ChemotaxisAbstract
Objective: Immune activation is an effective as well as protective approach against emerging infectious diseases. To screen for in-vitro immuno-modulatory activity of Mukta Bhasma (Calx of cultured Pearl) on human neutrophils. Methods: Mukta Bhasma (MB) was subjected to In-vitro screening to assess its Immunomodulatory effect using the Nitroblue Tetrazolium (NBT) assay, Phagocytosis & Candidacidal assay, Neutrophil locomotion and Chemotaxis test at five different doses of test drug (1mg, 0.5mg, 0.25mg, 0.125mg, 0.06mg). Results: Mukta bhasma has shown significant (p<0.001) increase in the % of NBT- stimulated cells and candida cells at 0.06mg. MB 0.125mg and MB 0.25 mg showed significant increase (p<0.01) in the candida cells when compared to MB 1.0mg. MB 0.06mg shows significant (p<0.001) increase in the phagocytic activity when compared to other doses of MB. MB showed significant (p<0.001) neutrophil and chemotactic activity at the dose of 0.06 mg and 0.125 mg. Mukta bhasma has shown significant(p<0.001) increase in all the parameters at the dose of 0.06 mg when compared to other doses of MB. Conclusion: The results were self-conclusive and indicated that Mukta Bhasma is immune- potent and showed immuno-modulatory effect at lower doses. Thus, the study revalidates the reference of Mukta Bhasma as a Rasayan and hence also establishing it as an Immunomodulator.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 International Journal of Ayurvedic Medicine

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The author hereby transfers, assigns, or conveys all copyright ownership to the International Journal of Ayurvedic Medicine (IJAM). By this transfer, the article becomes the property of the IJAM and may not be published elsewhere without written permission from the IJAM.
This transfer of copyright also implies transfer of rights for printed, electronic, microfilm, and facsimile publication. No royalty or other monetary compensation will be received for transferring the copyright of the article to the IJAM.
The IJAM, in turn, grants each author the right to republish the article in any book for which he or she is the author or editor, without paying royalties to the IJAM, subject to the express conditions that (a) the author notify IJAM in advance in writing of this republication and (b) a credit line attributes the original publication to IJAM.